Enovis (ENOV) Revenue (QoQ) (2010 - 2026)
Enovis (ENOV) Revenue (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn |
| 10 | Enovis | 1.60 Bn | 1.56 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 2.33% |
| Dec 31, 2025 | 4.89% |
| Oct 3, 2025 | -2.77% |
| Jul 4, 2025 | 1.02% |
| Apr 4, 2025 | -0.38% |
| Dec 31, 2024 | 11.04% |
| Sep 27, 2024 | -3.80% |
| Jun 28, 2024 | 1.72% |
| Mar 29, 2024 | 13.46% |
| Dec 31, 2023 | 8.98% |
| Sep 29, 2023 | -2.56% |
| Jun 30, 2023 | 5.50% |
| Mar 31, 2023 | -0.63% |
| Dec 31, 2022 | 6.49% |
| Sep 30, 2022 | -2.86% |
| Jul 1, 2022 | 5.24% |
| Apr 1, 2022 | -5.91% |
| Dec 31, 2021 | 10.87% |
| Oct 1, 2021 | 1.07% |
| Jul 2, 2021 | 14.48% |